These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 25502131)

  • 1. Managing bleeding and emergency reversal of newer oral anticoagulants: a review for primary care providers.
    Peacock WF
    Hosp Pract (1995); 2014 Oct; 42(4):75-82. PubMed ID: 25502131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
    Cheng JW; Barillari G
    J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New oral anticoagulants: clinical indications, monitoring and treatment of acute bleeding complications.
    Fenger-Eriksen C; Münster AM; Grove EL
    Acta Anaesthesiol Scand; 2014 Jul; 58(6):651-9. PubMed ID: 24716468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer clinically available antithrombotics and their antidotes.
    Lévy S
    J Interv Card Electrophysiol; 2014 Sep; 40(3):269-75. PubMed ID: 24934756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay.
    Wong PC; White A; Luettgen J
    Hosp Pract (1995); 2013 Feb; 41(1):19-25. PubMed ID: 23466964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation: a GP primer on the new oral anticoagulants.
    Brieger D
    Aust Fam Physician; 2014 May; 43(5):254-9. PubMed ID: 24791763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S; Ansell J
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
    Dumont B; Faille D; Ajzenberg N
    Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing new oral anticoagulants in the intensive care unit.
    Gass JA; Weeks PA
    Crit Care Nurs Q; 2013; 36(4):390-9. PubMed ID: 24002428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient management of oral anticoagulation in atrial fibrillation.
    Manning JA
    Crit Care Nurs Clin North Am; 2013 Dec; 25(4):481-7, vi. PubMed ID: 24267284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory monitoring of the non-vitamin K oral anticoagulants.
    Blann AD; Lip GY
    J Am Coll Cardiol; 2014 Sep; 64(11):1140-2. PubMed ID: 25212649
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel oral anticoagulants: a review of new agents.
    Wanat MA
    Postgrad Med; 2013 Jul; 125(4):103-14. PubMed ID: 23933899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel oral anticoagulants: efficacy, laboratory measurement, and approaches to emergent reversal.
    Gehrie E; Tormey C
    Arch Pathol Lab Med; 2015 May; 139(5):687-92. PubMed ID: 25927153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
    Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
    Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
    Quinlan DJ; Eriksson BI
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management.
    Douketis JD
    Curr Pharm Des; 2010; 16(31):3436-41. PubMed ID: 20858185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of the novel oral anticoagulants dabigatran, rivoraxaban, and apixaban.
    Liotta EM; Levasseur-Franklin KE; Naidech AM
    Curr Opin Crit Care; 2015 Apr; 21(2):127-33. PubMed ID: 25689124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development.
    Ufer M
    Thromb Haemost; 2010 Mar; 103(3):572-85. PubMed ID: 20135071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.